FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称SOCAZOLIMAB
异名/同义词IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL ZKAB001 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ZKAB001 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(HOMO SAPIENS CD274 (PROGRAMMED CELL DEATH 1 LIGAND 1, B7H1, B7-H1, PDL1, PD-L1, PDCD1L1, B7 HOMOLOG 1)), MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-449) (VH (HOMO SAPIENS IGHV1-69*01 (98.0%)-(IGHD)-IGHJ6*01 (94.7%), CDR-IMGT (8.8.12) (26-33.51-58.97-108)) (1-119)-HOMO SAPIENS IGHG1*01 (100%), G1M17,1 (CH1 K120 (216) (120-217), HINGE 1-15 (218-232), CH2 (233-342), CH3 D12 (358), L14 (360) (343-447), CHS (448-449)) (120-449)), (222-214')-DISULFIDE WITH LAMBDA2 LIGHT CHAIN (1'-215') (V-LAMBDA (HOMO SAPIENS IGLV2-23*02 (90.8%)-IGLJ2*01 (100%), CDR-IMGT (9.3.10) (26-34.52-54.90-99)) (1'-109')-HOMO SAPIENS IGLC2*01 (100%) (110'-215')); DIMER (228-228'':231-231'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO)-K1SV CELL LINE LACKING THE GLUTAMINE SYNTHETASE GENE (GSKO), GLYCOFORM ALFA
SH1E2
SOCAZOLIMAB
SOCAZOLIMAB [INN]
SOCAZOLIMAB [USAN]
SOCAZOLIMAB [WHO-DD]
STI-A1014
ZKAB001
ZKAB-001
CAS登记号2305043-30-3
物质唯一标识(Unique Ingredient Identifier)82P4S8Q3FB
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System